Omni Star Financial Group, Inc. Gilead Sciences, Inc. Transaction History
Omni Star Financial Group, Inc.
- $117 Million
- Q4 2024
A detailed history of Omni Star Financial Group, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Omni Star Financial Group, Inc. holds 17,784 shares of GILD stock, worth $2.09 Million. This represents 1.4% of its overall portfolio holdings.
Number of Shares
17,784
Previous 9,907
79.51%
Holding current value
$2.09 Million
Previous $830,000
97.83%
% of portfolio
1.4%
Previous 0.66%
Shares
28 transactions
Others Institutions Holding GILD
# of Institutions
2,099Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$14.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$13.6 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$8.42 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$7.09 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.8 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $147B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...